Palvella Therapeutics (PVLA) EBIT (2013 - 2026)
Palvella Therapeutics' EBIT was -$21.41 million in Q2 2026, compared with -$9.25 million a year earlier.
Powered by 
Analysis
Palvella Therapeutics (PVLA) EBIT (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Palvella Therapeutics' EBIT was -$57.74 million through Jun 30, 2026; for FY2025, it came in at -$38.6 million.
- In earlier years, EBIT was -$14.1 million in FY2024, -$11.87 million in FY2023, -$43.47 million in FY2022 and -$51.83 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBIT in data going back to Q2 2013.
- Per Business Quant data, PVLA's EBIT in the three quarters before Q2 2026 was -$14.86 million (Q1 2026), -$11.3 million (Q4 2025) and -$10.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | -21.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.41 Mn |
| Mar 31, 2026 | -14.86 Mn |
| Dec 31, 2025 | -11.30 Mn |
| Sep 30, 2025 | -10.18 Mn |
| Jun 30, 2025 | -9.25 Mn |
| Mar 31, 2025 | -7.87 Mn |
| Dec 31, 2024 | -4.37 Mn |
| Sep 30, 2024 | -5.06 Mn |
| Jun 30, 2024 | -2.91 Mn |
| Mar 31, 2024 | -1.76 Mn |
| Dec 31, 2023 | 13.39 Mn |
| Sep 30, 2023 | -11.81 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | -15.51 Mn |
| Dec 31, 2022 | -11.52 Mn |
| Sep 30, 2022 | -12.17 Mn |
| Jun 30, 2022 | -12.33 Mn |
| Mar 31, 2022 | -7.46 Mn |
| Dec 31, 2021 | -11.00 Mn |
| Sep 30, 2021 | -19.01 Mn |
API Access
Palvella Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();